Analysis and Opinion: Indra Sistemas ($IDR) — Record portfolio, net cash, and the resolution of the CNMV issue

Before getting into the thesis

The Scenario Table

Every time I open a position with this conviction, I prefer to first put in writing my thoughts on the range of possible outcomes. I don’t work with a single target price, but rather with three scenarios that reflect different combinations of portfolio performance, changes in the P/E ratio, and the outcome of the corporate noise surrounding the stock.

Reference entry price: below €50, as of June 26, 2026. Our own target prices; not consensus estimates, except for the base-case scenario.

Why I Bought It

The best balance sheet in its history at a bargain price

Indra closed the first quarter of 2026 with a A record order backlog of 20,334 million euros, up 154% from a year earlier. The Defense segment's portfolio alone exceeded 11.4 billion, a 2,79% year-over-year increase, driven by the Spanish government’s Special Modernization Programs (PEM) and international partnerships with Hanwha, Rheinmetall, Diehl, and ELT. The book-to-bill ratio stood at 2.14 times: The company is securing orders at more than twice the rate at which it generates revenue.

Profitability is strong. EBIT for the quarter rose 24% to 118 million, with the Defense division's margin at a remarkable 18,1%. But what I like most about this case is the bottom line: Indra It has no debt; it has a net cash position. about 855 million, which gives it the flexibility to finance its industrial expansion (new plants in León and Córdoba in Q3) and undertake more than twenty potential M&A transactions without raising capital or taking on debt.

The company has confirmed its guidance for 2026: revenue exceeding 7 billion euros, EBIT above 700 million, and free cash flow above 375 million. And the most significant factor from a valuation perspective is that is trading at a discount compared to its European peers — The estimated 2027 P/E ratio for the defense segment is around 19 times, compared to the sector average of 23 times. The market is allowing me to buy the Spanish leader (~42% of the national defense budget in 2025) at a lower price than its peers, precisely because of the corporate noise.

The noise that gave me the opportunity

FCAS, Rheinmetall, and the Battle for Control

The first blow was the FCAS failure, the sixth-generation European fighter jet program. On June 8, Germany and France called off their cooperation after years of dispute between Dassault and Airbus over leadership of the project, and Spain—with Indra as its technology partner and leader of the sensors and combat cloud pillar—found itself in an awkward position. The market punished the stock as if Indra had lost a contract that had already been signed, when in reality it was a long-term prospect.

The second blow came on June 24, just two days before I started, when Rheinmetall plummeted by as much as 18% Following the cancellation of Germany’s F126 frigate program, which dragged down the entire European defense sector. Indra fell more than 4% that day simply due to sector-wide correlation, without any news specific to the company. And looming over it all was the corporate governance battle: Escribano’s departure, the standoff with SEPI, and the AQR fund, which held a short position that at one point exceeded 2.4% of the company’s capital.

A front that is closing in

The CNMV and the Escribanos' Departure

For months, the shadow of the sale of 14.3% of the company's shares carried out by the Escribano family through its vehicle EM&E, a transaction worth more than 1.3 billion euros involving derivatives and financing from JPMorgan, which led to questions in Congress about possible insider trading.

On July 8, that uncertainty was cleared up. According to a report by Expansión, The CNMV has already received the requested information and has concluded its investigation into the sale. The transaction, in which the Escribanos made a net profit of about 195 million euros, has been closed from the regulator’s perspective, with no investigation opened. For me, this is exactly what I wanted: one less source of uncertainty, which leaves Indra with a more streamlined corporate governance structure and SEPI as the largest stable shareholder with a 28% stake.

Technical Analysis

The entry at a previously tested support level

The stock has seen a wide range of movement over the past twelve months: it started from a consolidation base between the 48 and 52 euros during October and December 2025; from there, it staged a rally that took it to its 52-week high in the region of 66–68 euros earlier this year, and subsequently underwent a severe correction that brought it back down to 48 euros in April. From there, it attempted a rebound to 58–60 euros in June, a rebound that has gradually faded, bringing the price back down to the the same 49-50 euro range that served as a support level a year ago.

A support level that has been tested several times and has held up gains reliability each time it is retested, and that is exactly the area where I have decided to build my position. It’s no coincidence that my bearish scenario, with a target of 44 euros, lies just below this support level: if it were to break through it decisively, it would be a sign that the market is pricing in more than just corporate noise.

The RSI (14) stands at 43.25, below the neutral line of 50 but far from the oversold zone of 30, reflecting a corrective and consolidation phase, not a capitulation. The The MACD shows the main line crossing above its signal line After months of bearish crossovers, although the indicator as a whole continues to trade below the zero line—a typical sign that a stock has put the worst of the correction behind it and is beginning to show the first signs of positive momentum.

Target Price and Catalysts

Back to Consensus, and a Little More

Analysts' consensus remains clearly positive. Of the 16 firms that cover the stock, the average recommendation is "buy," with a average target price in the range of 63–64 euros, with estimates ranging from 58 euros at Bankinter to highs of around 66–75 euros in the most optimistic projections. My own target price is 66 euros, supported by the conversion of its record portfolio into revenue, net cash that allows for growth without dilution, and a potential re-rating of its multiples if corporate noise subsides.

Risks of the thesis

Real Risks I See at Indra

Synthesis

Asymmetry in its purest form

The most honest summary of this type of post is always the same: A downside limited by the fundamentals themselves, an upside open to a multiple re-rating, and a time-based catalyst that does not depend on anything extraordinary happening in the business. I haven't bought into a promise of future growth that has yet to be proven. I've bought into an existing order backlog, a balance sheet that already shows a net cash position, and a margin of safety that is already above 18%.

Even in the pessimistic scenario, the decline from my entry price is limited—around 10%—because I already bought the stock with a significant discount already factored in. In the base scenario, which is simply the market consensus without any heroic assumptions, the potential is around 30%. And in the optimistic scenario, which requires only that the market stop applying the governance discount, the upside potential exceeds 55%.